Lemaitre Vascular (LMAT) Net Equity Issued and Repurchased (2010 - 2023)

Lemaitre Vascular (LMAT) has reported Net Equity Issued and Repurchased for 14 consecutive years, with $1.1 million the latest figure, recorded in Q4 2023.

• In Q4 2023, Net Equity Issued and Repurchased fell 38.61% year-over-year to $1.1 million; the TTM figure through Dec 2023 stood at $3.9 million (up 12.26% YoY), while the FY2024 annual figure was $6.4 million, up 4.38% from the prior year.
• Net Equity Issued and Repurchased fell to $1.1 million in Q4 2023 per LMAT's latest filing, from $1.8 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $59.5 million in Q3 2021 and bottomed at $43000.0 in Q2 2020.
• Historically, Net Equity Issued and Repurchased has averaged $4.6 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 5020.84% — and 2022, when it sank 98.31%.
• Lemaitre Vascular's Net Equity Issued and Repurchased stood at $1.7 million in 2019, then jumped by 163.91% to $4.5 million in 2020, then slumped by 63.06% to $1.7 million in 2021, then climbed by 6.69% to $1.8 million in 2022, then plunged by 38.61% to $1.1 million in 2023.
• Business Quant data shows LMAT's Net Equity Issued and Repurchased at $1.1 million in Q4 2023, $1.8 million in Q4 2022, and $1.0 million in Q3 2022.